The Center for Psychedelic Research is recreating real life scenarios to better understand how drugs and alcohol affect the ...

Researchers used EEG to study high-dose inhaled 5-MeO-DMT in humans. Unlike other psychedelics, the drug reduced brain ...

Rick Doblin had come to believe that psychedelic experiences are the "common core" of all religions, and he wanted to test this thesis. In February 1984, the 31-year-old college student living off a ...

A small biopharma company said its experimental depression drug is moving into Phase 3 trials, sending its shares soaring about 35% in premarket trading on Monday.

A sweeping bill would fund the VA to examine ketamine, magic mushrooms and other hallucinogens for potential medical use for ...

Even more interest in alternative therapies is growing beyond clinics. The state of Texas is investing $50 million in ...

Drugmaker Lykos Therapeutics announced on Aug. 9, 2024, that the Food and Drug Administration declined to approve the company’s application for the use of MDMA-assisted therapy in the treatment of ...

The future of psychedelic research was dealt its biggest setback in years after the FDA declined to approve midomafetamine (MDMA) capsules for post-traumatic stress disorder (PTSD) earlier this month, ...

From magic mushrooms to peyote, psychedelics have made a name for themselves in recent years as potential therapeutics for a range of different conditions, including post-traumatic stress disorder, ...

Biotech company MindMed is shoring up its cash stockpile to inch its psychedelic therapies towards approval after the feds’ recent thumbs-down of using MDMA to treat post-traumatic stress disorder.

Students for Sensible Drug Policy (SSDP) legal team, staff, scientific witnesses and science policy committee members outside of the Drug Enforcement Administration’s (DEA) Springfield, Virginia, ...